Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 07, 2026 08:00 ET | Source: Ethos Laboratories

Ethos Laboratories Announces Exclusive U.S. Launch of CNSDose™, Following Successful MolDX® Technical Assessment

Ethos Laboratories announces the exclusive U.S. launch of CNSDose™ following a successful MolDX® Technical Assessment.
June 02, 2025 08:30 ET | Source: Pinnacle Treatment Centers

Pinnacle Treatment Centers Introduces New Opioid Treatment Options in California: Sublocade and Vivitrol

Canoga Park, California, June 02, 2025 (GLOBE NEWSWIRE) -- Aegis Treatment Centers, part of the Pinnacle Treatment Centers Family of Companies, a leader in providing evidence-based care for...
March 05, 2025 09:48 ET | Source: Spark Biomedical

Spark Biomedical Receives Health Canada’s Medical Device License for Sparrow Ascent Opioid Withdrawal Treatment

Dallas, TX, March 05, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, announces the receipt of its Medical Device License from Health Canada for Sparrow...
December 27, 2024 17:14 ET | Source: American College of Medical Toxicology

Pioneering Toxicology Research Takes Center Stage at 2025 ACMT Annual Meeting in Vancouver

Phoenix, AZ, Dec. 27, 2024 (GLOBE NEWSWIRE) -- The American College of Medical Toxicology (ACMT) is pleased to announce its 2025 Annual Scientific Meeting (#ACMT2025) and Symposia on April 2 - 6 at...
November 18, 2024 10:48 ET | Source: Spark Biomedical

Spark Biomedical Sets Sights on Global Expansion with New ISO 13485 and MDSAP Certifications

Dallas, TX, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a leading developer of wearable neurostimulation devices, proudly announces the recent achievement of ISO 13485:2016 and MDSAP Quality...
September 12, 2024 13:39 ET | Source: Spark Biomedical

Spark Biomedical Awarded National Institute on Drug Abuse Funding to Develop AI-Algorithm for Opioid Withdrawal and Cravings Detection

Dallas, TX, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, is partnering with prestigious research and behavioral health institutes, Battelle...
August 06, 2024 09:00 ET | Source: Turning Point of Tampa

Turning Point of Tampa’s Dr. Hardeep Singh Recognized in Tampa Magazine’s TOP Doctors List for Third Consecutive Year

Tampa, FL, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Turning Point of Tampa is proud to announce that Dr. Hardeep Singh, our esteemed Medical Director, has been named to Tampa Magazine’s TOP Doctors List...
January 09, 2024 08:30 ET | Source: BioCorRx Inc

BioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as President

ANAHEIM, CA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and...
July 18, 2023 08:30 ET | Source: BioCorRx Inc

BioCorRx Submits Fast Track Application to FDA for BICX104, an Implantable Biodegradable Naltrexone Pellet for The Treatment of Opioid Use Disorder

ANAHEIM, CA, July 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and...
March 20, 2023 11:30 ET | Source: Transparency Market Research

Drug Testing Market Size to Cross USD 15.7 Bn by 2033 with CAGR of 5.3% | Transparency Market Research

Wilmington, Delaware, United States, March 20, 2023 (GLOBE NEWSWIRE) -- According to the latest research by Transparency Market Research, the drug testing market was estimated to attain a global...